Suppr超能文献

活化蛋白C在一例小儿感染性休克中的应用。

Use of activated protein C in a case of paediatric septic shock.

作者信息

Verre M, Barozzi E, Piccirillo M, Tancioni F, Tiburzi S, Varano M

机构信息

Anaesthesiology and Intensive Care Unit, S. Giovanni Di Dio Hospital, Crotone, Italy.

出版信息

Minerva Pediatr. 2005 Dec;57(6):429-32.

Abstract

We describe a clinical case of a 7 year old girl, affected by peritonitis, septic shock and multiorgan failure, treated successfully with drotrecogin alpha associated with conventional therapy.

摘要

我们描述了一名7岁女孩的临床病例,她患有腹膜炎、感染性休克和多器官功能衰竭,采用重组人活化蛋白C联合传统疗法成功治愈。

相似文献

2
Drotrecogin alpha (activated) in neonatal septic shock.
Scand J Infect Dis. 2005;37(4):306-8. doi: 10.1080/00365540510031412.
3
A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.
Clin Infect Dis. 2004 Dec 1;39(11):e122-3. doi: 10.1086/425918. Epub 2004 Nov 9.
4
Drotrecogin alpha (activated) in septic shock after lung transplant.
J Heart Lung Transplant. 2008 Jul;27(7):815. doi: 10.1016/j.healun.2008.04.002. Epub 2008 May 12.
6
[On activated protein C in septic shock].
Presse Med. 2006 Jun;35(6 Pt 1):989; author reply 989.
7
Activated protein C and septic shock: a propensity-matched cohort study*.
Crit Care Med. 2012 Nov;40(11):2974-81. doi: 10.1097/CCM.0b013e31825fd6d9.
9
"All in" for a huge pot: the PROWESS-SHOCK trial for refractory septic shock.
Surg Infect (Larchmt). 2007 Oct;8(5):491-4. doi: 10.1089/sur.2007.9980.
10
[Activated protein C in patients with septic shock: pro].
Dtsch Med Wochenschr. 2010 Nov;135(47):2370. doi: 10.1055/s-0030-1269402. Epub 2010 Nov 16.

引用本文的文献

1
Recombinant human activated protein C for severe sepsis in neonates.
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD005385. doi: 10.1002/14651858.CD005385.pub3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验